DAX Stock News Today – Baudax Bio Shares Increase Over 45% Pre-Market: Why It Happened

This article was originally published on this site

DAX Stock News Today – Baudax Bio Shares Increase Over 45% Pre-Market: Why It Happened

  • The shares of Baudax Bio Inc (NASDAQ: BXRX) increased by over 45% pre-market. This is why it happened.

The shares of Baudax Bio Inc (NASDAQ: BXRX) increased by over 45% pre-market. Investors appear to be responding positively to a Form 4 SEC filing.

The Form 4 SEC filing shows that Baudax Bio chief financial officer Richard Casten bought a significant number of shares in the company. Specifically, Casten bought 50,000 shares at a price of $0.51 each. 

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis. 

DAX Stock News Today – Baudax Bio Shares Increase Over 45% Pre-Market: Why It Happened